Clinical Trials Directory

Trials / Completed

CompletedNCT05782816

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: A Randomized Control Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
170 (actual)
Sponsor
The University of Texas Medical Branch, Galveston · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare oxytocin infusion rates for induction and augmentation of labor in nulliparous women. The main question\[s\] it aims to answer are: * Does a high dose oxytocin infusion protocol affect length of induction to delivery interval? * Does a high dose oxytocin infusion protocol affect mode of delivery? * Does a high dose oxytocin infusion protocol affect maternal and neonatal outcomes? Participants will be randomized to either low- or high-dose oxytocin groups: * The low dose group will receive an infusion to start at 2 milli-units/min and will be increased by 2 milli-units/min every 20 minutes. The maximum rate of infusion is 40 milli-units/min. * The high dose group will receive an infusion to start at 6 milli-units/min and will be increased by 6 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin (Low dose)Low dose oxytocin
DRUGOxytocin (High dose)High dose oxytocin

Timeline

Start date
2023-04-17
Primary completion
2024-12-31
Completion
2025-06-24
First posted
2023-03-24
Last updated
2026-01-09
Results posted
2026-01-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05782816. Inclusion in this directory is not an endorsement.